NEW YORK (GenomeWeb News) – Waters has sold $200 million in senior notes in a private placement, it said in a filing with the US Securities and Exchange Commission today.

The firm sold three series of notes in the placement: $100 million of 3.4 percent Series F Senior Notes, due June 30, 2021; $50 million of 3.92 percent Series G Senior Notes, due June 30, 2024; and $50 million of Series H Floating Rate Senior Notes bearing interest at 3 month LIBOR plus 1.25 percent, due June 30, 2024.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.